Evidence map›Paper›PMID 32928929›Full record

ArticleJournal of bacteriology2020

Riboswitch-Associated Guanidinium-Selective Efflux Pumps Frequently Transmitted on Proteobacterial Plasmids Increase Escherichia coli Biofilm Tolerance to Disinfectants.

Carmine J Slipski, Taylor R Jamieson, George G Zhanel, Denice C Bay

Open access · greenAbstract read
In one paragraph

Article in Journal of bacteriology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Characterization of Proteobacterial Plasmid Integron-EncodedAntimicrobial agents and chemotherapy · 2021
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Carmine J Slipski *University of Manitoba, Medical Microbiology and Infectious Disease, Winnipeg, Manitoba, Canada.
Taylor R Jamieson *University of Manitoba, Medical Microbiology and Infectious Disease, Winnipeg, Manitoba, Canada.ORCID 0000-0002-7234-1395
George G ZhanelUniversity of Manitoba, Medical Microbiology and Infectious Disease, Winnipeg, Manitoba, Canada.
Denice C BayUniversity of Manitoba, Medical Microbiology and Infectious Disease, Winnipeg, Manitoba, Canada Denice.Bay@umanitoba.ca.ORCID 0000-0002-3620-828X
University of Manitoba · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Members of the small multidrug resistance (SMR) efflux pump family known as SugE (recently renamed Gdx) are known for their narrow substrate selectivity to small guanidinium (Gdm

Indexed as

BiofilmsDisinfectantsDrug Resistance, BacterialEscherichia coliEscherichia coli ProteinsGuanidineMembrane Transport ProteinsMicrobial Sensitivity TestsPlasmidsProteobacteriaQuaternary Ammonium CompoundsRiboswitchDisinfectantsEscherichia coli ProteinsGuanidineMembrane Transport ProteinsQuaternary Ammonium CompoundsRiboswitchantisepticbiocidebiofilmdisinfectantdisinfectant resistanceefflux pumpGdxguanidiniummultidrug resistance plasmidsplasmidquaternary ammonium compound (QAC)riboswitchsmall multidrug resistance proteinssmall multidrug resistance (SMR)SugE

Identifiers

PMID32928929
PMCPMC7648145
OpenAlexW3084771467

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.